FDA Drug recall D-0042-2021
Desflurane, USP Liquid for Inhalation, 240 mL, Rx Only, Manufactured by: Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, 200245, China…
- FDA Drug
- Class III
- terminated
- Published 2020-10-28
On 2020-10-28 the FDA classified a Class III recall of Desflurane, USP Liquid for Inhalation, 240 mL, Rx Only, Manufactured by: Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, 200245, China… by Evenus Pharmaceutical Laboratories, citing DEFECTIVE CONTAINER: Desflurane Liquid for Inhalation 240 mL may be leaking.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0042-2021 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2020-10-06 |
| Published | 2020-10-28 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Evenus Pharmaceutical Laboratories |
| Distribution | CO |
Product
Desflurane, USP Liquid for Inhalation, 240 mL, Rx Only, Manufactured by: Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, 200245, China for Sandoz Inc. Princeton, NJ 08540, NDC 0781-6172-22
Reason
DEFECTIVE CONTAINER: Desflurane Liquid for Inhalation 240 mL may be leaking.
Identifiers
| ndc | 0781-6172-22 |
|---|---|
| ndc | 0781-6172-86 |
| code_info | Lot #: 20011831, Exp. Date 12/2021; 20041431, Exp. Date 03/2022 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0042-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.